Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Atranorin
Cat. No.:
OB0225LY-0062
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Atranorin is a natural product derived mainly from certain mosses. It exhibits a variety of biological activities, including antimicrobial and antioxidant activities.
Synonym:
479-20-9; Atranoric acid; Atranorine; 3-Hydroxy-4-(methoxycarbonyl)-2,5-dimethylphenyl 3-formyl-2,4-dihydroxy-6-methylbenzoate; Methyl 1-(3-formyl-2,4-dihydroxy-6-methylphenylcarbonyloxy)-3-hydroxy-2,5-dimethyl-4-benzenecarboxylate
CAS No.:
479-20-9
Compound CID:
68066
Formula:
C19H18O8
Formula Weight:
374.34
Specification
Relative Density:
1.404 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Atranorin can be used for antimicrobial and anti-inflammatory drug development.
Library Information
Targets:
NO synthase family; Ras family
Pathways:
Metabolism; GPCR/G protein; Immunology/Inflammation; MAPK
Plate Number:
AOCL-1
Plate Location:
g4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM Water
Solubility:
Slightly soluble in DSMO.
